Opinion | ‘A Real Regulatory Dilemma Here’: What We Heard This Week
“It’s a real regulatory dilemma here.” — Donald Kohn, MD, of the University of California Los Angeles, at an FDA advisory committee meeting to discuss
“It’s a real regulatory dilemma here.” — Donald Kohn, MD, of the University of California Los Angeles, at an FDA advisory committee meeting to discuss
HOUSTON — Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after surgery versus placebo, according to
Baloescu is an emergency physician, assistant professor, and AI researcher. Microsoft’s new artificial intelligence (AI)-powered healthcare suite plans to “shape a healthier future” through advances
Vaping among ex-smokers in England surged from 2% in 2013 to over 20% in 2024, driven by younger demographics and disposable e-cigarettes, raising questions about
Around 450,000 children are being failed by the UK education system because they have a special educational need and disability (SEND) that is effectively unrecognised
Prenatal exposure to maternal pro-inflammatory cytokines shapes memory and immune function in offspring, with sex-specific effects emerging over 50 years.
Health officials in California have discovered bird flu virus in raw milk for sale in a store in the state, a development scientists following the